Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Bias voltage generating circuit and switching power supply thereof
Magnetic element with top shield coupled side shield lamination
Methods and compositions for improving photodynamic therapy through administration of lipids
Method of manufacturing acrylic film, and acrylic film
Curved structural part made of composite material and a process for manufacturing such a part
Electrical event detection device and method of detecting and classifying electrical power usage
  Randomly Featured Patents
Rapid setting high strength calcium phosphate cements comprising cyclodextrins
Metal oxide semiconductor (MOS) bandgap voltage reference circuit
Electrorheological fluid composition including hydrocarbon compound having at least one unsaturated bond
Installation for transmitting alarm signals
Flexible tube for carrying heating or refrigerant fluids
Method of determining the similarity of two strings
Flutter lift for torque wrench
Rolling bearing
Process for producing adipic acid diester